Adaptimmune Therapeutics PLC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
New Enterprise Associates funds significantly reduced their beneficial ownership in Adaptimmune Therapeutics Plc through recent open market sales.